Y-mAbs Names Peter Pfreundschuh as CFO

Monday, 1 July 2024, 20:14
Y-mAbs Therapeutics announces the appointment of Peter Pfreundschuh as the Chief Financial Officer effective from June 28, 2024. Pfreundschuh brings a wealth of experience in financial management to the organization, which is expected to drive strategic financial decision-making and enhance the company's future growth trajectory.
LivaRava Finance Meta Image
Y-mAbs Names Peter Pfreundschuh as CFO

CFO Appointment at Y-mAbs Therapeutics

Y-mAbs Therapeutics has named Peter Pfreundschuh as its new Chief Financial Officer (CFO), starting from June 28, 2024. Pfreundschuh is set to play a crucial role in overseeing the financial aspects of the company, with a focus on strategic planning and growth initiatives.

Key Points:

  • Peter Pfreundschuh appointed as CFO of Y-mAbs Therapeutics
  • Effective from June 28, 2024
  • Expectations of strategic financial decision-making and enhancing growth trajectory
Do you want to advertise here? Contact us

Related posts

Do you want to advertise here? Contact us
Do you want to advertise here? Contact us
Newsletter

We carefully select news from the world of finance and publish it for our users. We understand the importance of reliable and up-to-date information for people in the financial world. Do you want to receive news in a convenient format and always have it at hand — subscribe to our newsletter and make your analytical work more effective.

Subscribe